Stocks-CPRX-Catalyst Pharmaceuticals Inc

CPRX Catalyst Pharmaceuticals Inc

12.85 0.12 (0.95%)
Market OpenDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Catalyst Pharmaceuticals Inc's revenues increased by 52.10% and amounted to 214.20M. Net income increased by 110.42% to 83.08M. Net assets increased by 45.25% to 300.42M and EPS increased from 0.37 to 0.75.
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment